Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism

J Pediatr Endocrinol Metab. 2017 Oct 26;30(10):1111-1118. doi: 10.1515/jpem-2017-0035.

Abstract

Background: Congenital hypogonadotropic hypogonadism (CHH) is classified as Kallmann syndrome (KS) with anosmia/hyposmia or normosmic (n)CHH. Here, we investigated the genetic causes and phenotype-genotype correlations in Japanese patients with CHH.

Methods: We enrolled 22 Japanese patients with CHH from 21 families (18 patients with KS and 4 with nCHH) and analyzed 27 genes implicated in CHH by next-generation and Sanger sequencing.

Results: We detected 12 potentially pathogenic mutations in 11 families, with three having a mutation in ANOS1 (X-linked recessive); three and four having a mutation in FGFR1 and CHD7, respectively (autosomal dominant); and one having two TACR3 mutations (autosomal recessive). Among four patients with KS carrying a CHD7 mutation, one had perceptive deafness and two had a cleft lip/palate.

Conclusions: The frequency of CHH genes in the Japanese was compatible with previous reports, except that CHD7 mutations might be more common. Furthermore, partial phenotype-genotype correlations were demonstrated in our cohort.

Keywords: ANOS1; CHD7; FGFR1; Kallmann syndrome; hypogonadotropic hypogonadism.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • DNA Helicases / genetics
  • DNA-Binding Proteins / genetics
  • Extracellular Matrix Proteins / genetics
  • Female
  • Humans
  • Hypogonadism / diagnosis*
  • Hypogonadism / genetics
  • Infant
  • Kallmann Syndrome / diagnosis*
  • Kallmann Syndrome / genetics
  • Male
  • Mutation*
  • Nerve Tissue Proteins / genetics
  • Receptor, Fibroblast Growth Factor, Type 1 / genetics
  • Young Adult

Substances

  • ANOS1 protein, human
  • DNA-Binding Proteins
  • Extracellular Matrix Proteins
  • Nerve Tissue Proteins
  • FGFR1 protein, human
  • Receptor, Fibroblast Growth Factor, Type 1
  • DNA Helicases
  • CHD7 protein, human